Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (HKG:2667)
Hong Kong · Delayed Price · Currency is HKD 2.445
-0.120 (-4.68%)
At close: Sep 1, 2026
HKG:2667 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 24.63 | 27.48 | 36.86 | 22.34 | -16.3 |
Depreciation & Amortization | 68.22 | 67.69 | 59.6 | 51.28 | 54.65 |
Other Amortization | 5.55 | 5.55 | 4.82 | 3.11 | 2.23 |
Loss (Gain) From Sale of Assets | 0.04 | 0.05 | -17.01 | 0.02 | 1.01 |
Loss (Gain) From Sale of Investments | 0.59 | 0.6 | -0.44 | 0.27 | -0.15 |
Loss (Gain) on Equity Investments | 0.22 | -0.1 | -0.11 | -2.03 | -0.31 |
Other Operating Activities | 8.63 | 16.23 | 7.79 | 29.26 | 17.69 |
Change in Accounts Receivable | -24.91 | 24.45 | 23.67 | -77.82 | -6.36 |
Change in Inventory | -4.53 | -2.3 | 1.75 | 21.9 | -39.68 |
Change in Accounts Payable | 8.09 | -11.56 | -40.25 | 71.56 | 60.02 |
Change in Other Net Operating Assets | -43.69 | -8.19 | 11.11 | -31.39 | -48.39 |
Operating Cash Flow | 43.35 | 119.91 | 87.79 | 88.49 | 24.42 |
Operating Cash Flow Growth | - | 36.59% | -0.80% | 262.41% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -21.56 | -17.04 | -11.94 | -23.82 | -31.8 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | - | 0.03 | - |
Cash Acquisitions | - | -9.1 | -84.41 | -9.47 | -75.02 |
Divestitures | - | - | -0.72 | - | - |
Sale (Purchase) of Intangibles | -4.55 | -5.26 | -6.05 | -8.14 | -4.86 |
Investment in Securities | -50 | -56 | 0.79 | - | -19.38 |
Other Investing Activities | 5.93 | 5.44 | - | 4.9 | - |
Investing Cash Flow | -70.16 | -81.95 | -102.32 | -36.5 | -131.06 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Long-Term Debt Issued | - | 67.08 | 111.3 | 5.68 | 132.63 |
Long-Term Debt Repaid | - | -101.61 | -113.6 | -53.73 | -31.54 |
Net Debt Issued (Repaid) | -53.34 | -34.53 | -2.3 | -48.05 | 101.09 |
Issuance of Common Stock | - | - | 67.5 | - | 100 |
Common Dividends Paid | -10.99 | -10.99 | -16.95 | -25.54 | - |
Other Financing Activities | -2.62 | -1.48 | -30.02 | -11.53 | -69.28 |
Financing Cash Flow | -66.95 | -46.99 | 18.23 | -85.12 | 131.81 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Cash Flow | -93.75 | -9.03 | 3.7 | -33.13 | 25.16 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 21.79 | 102.87 | 75.85 | 64.68 | -7.39 |
Free Cash Flow Growth | - | 35.61% | 17.28% | - | - |
Free Cash Flow Margin | 1.98% | 8.78% | 6.46% | 5.61% | -0.81% |
Free Cash Flow Per Share | 0.06 | 0.29 | 0.22 | 0.22 | -0.03 |
Levered Free Cash Flow | - | 76.47 | 12.26 | 25.15 | - |
Unlevered Free Cash Flow | - | 84.58 | 21.18 | 32.21 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Income Tax Paid | 17.72 | 18.52 | 23.23 | 22.64 | 9.68 |
Change in Working Capital | -65.05 | 2.4 | -3.72 | -15.75 | -34.42 |